| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
8-K
| Other Events Interactive Data |
| 05/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/17/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/03/2023 |
8-K
| Other Events Interactive Data |
| 03/29/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/28/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/24/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 03/16/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 02/22/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/21/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reports a 8% stake in GLOBUS MEDICAL INC |
| 02/10/2023 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 5.6% stake in GLOBUS MEDICAL, INC. |
| 02/09/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/09/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Agreement and Plan of Merger, by and among NuVasive, Inc., Globus Medical, Inc. and Zebra Merger Sub, Inc.* #",
"Voting and Support Agreement, by and among NuVasive, Inc., Globus Medical, Inc., David Paul and Sonali Paul" |
|
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in Globus Medical Inc. |
| 02/09/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/09/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/08/2022 |
8-K
| Quarterly results |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/04/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
|